These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35884469)

  • 1. Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test.
    Kim YN; Kim MK; Lee YJ; Lee Y; Sohn JY; Lee JY; Choi MC; Kim M; Jung SG; Joo WD; Lee C
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
    Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
    Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
    J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
    Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
    Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.
    Ring KL; Bruegl AS; Allen BA; Elkin EP; Singh N; Hartman AR; Daniels MS; Broaddus RR
    Mod Pathol; 2016 Nov; 29(11):1381-1389. PubMed ID: 27443514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of germline multi-gene panel testing in patients with endometrial cancer.
    Karpel HC; Chern JY; Smith J M; Smith A J; Pothuri B
    Gynecol Oncol; 2022 Jun; 165(3):546-551. PubMed ID: 35483985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing.
    Soares BL; Brant AC; Gomes R; Pastor T; Schneider NB; Ribeiro-Dos-Santos Â; de Assumpção PP; Achatz MIW; Ashton-Prolla P; Moreira MAM
    Fam Cancer; 2018 Jul; 17(3):387-394. PubMed ID: 28932927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of germline variants in Lynch syndrome-related genes among Japanese endometrial cancer patients aged 40 years or younger.
    Makabe T; Yamagami W; Hirasawa A; Miyabe I; Wakatsuki T; Kikuchi M; Takahashi A; Noda J; Yamamoto G; Aoki D; Akagi K
    Int J Clin Oncol; 2021 Sep; 26(9):1767-1774. PubMed ID: 34115236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
    Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
    Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch Syndrome in Thai Endometrial Cancer Patients.
    Manchana T; Ariyasriwatana C; Triratanachat S; Phowthongkum P
    Asian Pac J Cancer Prev; 2021 May; 22(5):1477-1483. PubMed ID: 34048176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants.
    Nikitin AG; Chudakova DA; Enikeev RF; Sakaeva D; Druzhkov M; Shigapova LH; Brovkina OI; Shagimardanova EI; Gusev OA; Gordiev MG
    Front Oncol; 2020; 10():666. PubMed ID: 32547938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
    Kempers MJ; Kuiper RP; Ockeloen CW; Chappuis PO; Hutter P; Rahner N; Schackert HK; Steinke V; Holinski-Feder E; Morak M; Kloor M; Büttner R; Verwiel ET; van Krieken JH; Nagtegaal ID; Goossens M; van der Post RS; Niessen RC; Sijmons RH; Kluijt I; Hogervorst FB; Leter EM; Gille JJ; Aalfs CM; Redeker EJ; Hes FJ; Tops CM; van Nesselrooij BP; van Gijn ME; Gómez García EB; Eccles DM; Bunyan DJ; Syngal S; Stoffel EM; Culver JO; Palomares MR; Graham T; Velsher L; Papp J; Oláh E; Chan TL; Leung SY; van Kessel AG; Kiemeney LA; Hoogerbrugge N; Ligtenberg MJ
    Lancet Oncol; 2011 Jan; 12(1):49-55. PubMed ID: 21145788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic
    Vogelaar IP; Greer S; Wang F; Shin G; Lau B; Hu Y; Haraldsdottir S; Alvarez R; Hazelett D; Nguyen P; Aguirre FP; Guindi M; Hendifar A; Balcom J; Leininger A; Fairbank B; Ji H; Hitchins MP
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing].
    Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive molecular assessment of mismatch repair deficiency in Lynch associated ovarian cancers using next generation sequencing panel.
    Kim SR; Oldfield L; Tone A; Pollett A; Pedersen S; Wellum J; Cesari M; Lajkosz K; Pugh TJ; Ferguson SE
    Int J Gynecol Cancer; 2023 Nov; ():. PubMed ID: 37940339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel heterozygous germline deletion in MSH2 gene in a five generation Chinese family with Lynch syndrome.
    Wu B; Ji W; Liang S; Ling C; You Y; Xu L; Zhong ME; Xiao Y; Qiu HZ; Lu JY; Banerjee S
    Oncotarget; 2017 Aug; 8(33):55194-55203. PubMed ID: 28903413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.